1. Home
  2. NYMTZ vs HUMAW Comparison

NYMTZ vs HUMAW Comparison

Compare NYMTZ & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYMTZ
  • HUMAW
  • Stock Information
  • Founded
  • NYMTZ N/A
  • HUMAW 2004
  • Country
  • NYMTZ United States
  • HUMAW United States
  • Employees
  • NYMTZ 70
  • HUMAW 220
  • Industry
  • NYMTZ Real Estate Investment Trusts
  • HUMAW Biotechnology: Pharmaceutical Preparations
  • Sector
  • NYMTZ Real Estate
  • HUMAW Health Care
  • Exchange
  • NYMTZ Nasdaq
  • HUMAW Nasdaq
  • Market Cap
  • NYMTZ N/A
  • HUMAW N/A
  • IPO Year
  • NYMTZ N/A
  • HUMAW N/A
  • Fundamental
  • Price
  • NYMTZ $18.01
  • HUMAW $0.51
  • Analyst Decision
  • NYMTZ
  • HUMAW
  • Analyst Count
  • NYMTZ 0
  • HUMAW 0
  • Target Price
  • NYMTZ N/A
  • HUMAW N/A
  • AVG Volume (30 Days)
  • NYMTZ N/A
  • HUMAW 14.2K
  • Earning Date
  • NYMTZ N/A
  • HUMAW 03-21-2025
  • Dividend Yield
  • NYMTZ N/A
  • HUMAW N/A
  • EPS Growth
  • NYMTZ N/A
  • HUMAW N/A
  • EPS
  • NYMTZ N/A
  • HUMAW N/A
  • Revenue
  • NYMTZ N/A
  • HUMAW N/A
  • Revenue This Year
  • NYMTZ N/A
  • HUMAW N/A
  • Revenue Next Year
  • NYMTZ N/A
  • HUMAW N/A
  • P/E Ratio
  • NYMTZ N/A
  • HUMAW N/A
  • Revenue Growth
  • NYMTZ N/A
  • HUMAW N/A
  • 52 Week Low
  • NYMTZ N/A
  • HUMAW $1.18
  • 52 Week High
  • NYMTZ N/A
  • HUMAW $1.34
  • Technical
  • Relative Strength Index (RSI)
  • NYMTZ 40.87
  • HUMAW N/A
  • Support Level
  • NYMTZ $17.68
  • HUMAW N/A
  • Resistance Level
  • NYMTZ $18.73
  • HUMAW N/A
  • Average True Range (ATR)
  • NYMTZ 0.28
  • HUMAW 0.00
  • MACD
  • NYMTZ -0.11
  • HUMAW 0.00
  • Stochastic Oscillator
  • NYMTZ 21.08
  • HUMAW 0.00

About NYMTZ New York Mortgage Trust Inc.

New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets. Geographically operates in USA states California, New York, Florida, New Jersey, Illinois, maximum from California.

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: